Immunohistochemical examination of CD163 and TROP2 expression levels in ovarian endometriosis

Endometriosis is described as an estrogen-associated, chronic, inflammatory disorder characterized by ectopic endometrial glands and stroma. Ovarian endometriosis, or endometrioma, presents as cystic lesions lined by endometrial tissue, with associated fibrosis and inflammation. Although the roles of immune and inflammatory markers in endometriosis have been investigated, the relationship between trophoblast cell surface antigen 2 (TROP2) and CD163 expression in ovarian endometriosis remains unexplored. This study is intended to evaluate immunohistochemical expression degrees of TROP2 and CD163 in ovarian endometriosis compared to normal ovarian tissue. Ovarian tissues from 26 patients with histologically confirmed endometriosis and 26 control subjects were analyzed retrospectively using immunohistochemistry. Semi-quantitative evaluation was performed via H-score analysis. Results showed significantly higher expression of both CD163 and TROP2 in ovarian endometriosis tissues compared to controls. A moderate, positive correlation was observed between CD163 and TROP2 expression. The findings demonstrate, for the first time, increased TROP2 expression in ovarian endometriosis, suggesting a potential role in the disease’s pathophysiology. Additionally, elevated CD163 expression indicates enhanced M2 (alternatively activated) macrophage infiltration, reflecting the inflammatory microenvironment of endometriotic tissue. These results may contribute to understanding the immunopathogenesis of ovarian endometriosis and establish a framework for further research into diagnostic or therapeutic applications targeting TROP2 and CD163. Similar content being viewed by others Data availability No datasets were generated or analysed during the current study. Abbreviations - CD: - Cluster of Differentiation - TROP2: - Trophoblast Cell Surface Antigen 2 - IL: - Interleukin - M-CSF: - Macrophage Colony-Stimulating Factor - LPS: - Lipopolysaccharide - TNF-α: - Tumor Necrosis Factor-Alpha - IFN-γ: - Interferon-Gamma - GM-CSF: - Granulocyte-Macrophage Colony-Stimulating Factor - H + BSO: - Hysterectomy with Bilateral Salpingo-Oophorectomy - HRP: - Horseradish Peroxidase - DAB: - 3,3 Diaminobenzidine - SG: - Sacituzumab Govitecan - FDA: - Food and Drug Administration - GA733-1: - Gastrointestinal Antigen 733-1 - EGP-1: - Epithelial Glycoprotein-1 - M1S1: - Membrane Component Chromosome 1 Surface Marker 1 - TAC-STD2: - Tumor Associated Calcium Signal Transducer 2 - SCARI1: - Scavenger Receptor Cysteine-Rich Type 1 Protein

Akashi K, Nagashima Y, Tabata T, Oda H (2021) Immunochemical analysis of iron transporters and M2 macrophages in ovarian endometrioma and clear cell adenocarcinoma. Mol Clin Oncol 15(2):159. https://doi.org/10.3892/mco.2021.2312 Bacci M, Capobianco A, Monno A, Cottone L, Di Puppo F, Camisa B, Mariani M, Brignole C, Ponzoni M, Ferrari S, Panina-Bordignon P, Manfredi AA, Rovere-Querini P (2009) Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol 175(2):547–556. https://doi.org/10.2353/ajpath.2009.081011 Bardia, A., Messersmith, W. A., Kio, E. A., Berlin, J. D., Vahdat, L., Masters, G.A., Moroose, R., Santin, A. D., Kalinsky, K., Picozzi, V., O’Shaughnessy, J., Gray,J. E., Komiya, T., Lang, J. M., Chang, J. C., Starodub, A., Goldenberg, D. M., Sharkey,R. M., Maliakal, P., Hong, Q., … Ocean, A. J. 2021. Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial. Annals of oncology: official journal of the European Society for Medical Oncology, 32(6), 746–756. https://doi.org/10.1016/j.annonc.2021.03.005 Bignotti E, Ravaggi A, Romani C, Falchetti M, Lonardi S, Facchetti F, Pecorelli S, Varughese J, Cocco E, Bellone S, Schwartz PE, Rutherford TJ, Santin AD (2011) Trop-2 overexpression in poorly differentiated endometrial endometrioid carcinoma: implications for immunotherapy with hRS7, a humanized Anti-Trop-2 monoclonal antibody. Int J Gynecol Cancer: Official J Int Gynecol Cancer Soc 21(9):1613–1621. https://doi.org/10.1097/IGC.0b013e31822d46ce Bignotti E, Zanotti L, Calza S, Falchetti M, Lonardi S, Ravaggi A, Romani C, Todeschini P, Bandiera E, Tassi RA, Facchetti F, Sartori E, Pecorelli S, Roque DM, Santin AD (2012) Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma. BMC Clin Pathol 12:22. https://doi.org/10.1186/1472-6890-12-22 Boyle JJ, Johns M, Lo J, Chiodini A, Ambrose N, Evans PC, Mason JC, Haskard DO (2011) Heme induces Heme Oxygenase 1 via Nrf2: role in the homeostatic macrophage response to intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 31(11):2685–2691. https://doi.org/10.1161/ATVBAHA.111.234872 Buechler C, Ritter M, Orsó E, Langmann T, Klucken J, Schmitz G (2000) Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol 67(1):97–103. https://doi.org/10.1002/jlb.67.1.97 Celik SY, Çelik Öİ (2020) Can TROP2 be used as a prognostic marker in endometrioid endometrial carcinoma?? Indian J Pathol Microbiol 63(3):418–422. https://doi.org/10.4103/IJPM.IJPM_734_19 Ceulemans A, Verhulst S, Van Haele M, Govaere O, Ventura JJ, van Grunsven LA, Roskams T (2017) RNA-Sequencing-Based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers. Cell Death Dis 8(11):e3164. https://doi.org/10.1038/cddis.2017.540 Cominelli A, Chevronnay G, Lemoine HP, Courtoy P, Marbaix PJ, E., Henriet P (2014) Matrix metalloproteinase-27 is expressed in CD163+/CD206 + M2 macrophages in the cycling human endometrium and in superficial endometriotic lesions. Mol Hum Reprod 20(8):767–775. https://doi.org/10.1093/molehr/gau034 Dabbs DJ (2022) Diagnostic immunohistochemistry, 6th edn. Elsevier Demir M, Elbe H, Cetinavci D, Saruhan E (2025) Effects of Troxerutin on oxidative stress, inflammation and Galectin- 3 expression in intracerebroventricular Kainic Acid-Induced neurotoxicity. Inflammation. https://doi.org/10.1007/s10753-025-02301-9Advance online publication El-Zayadi AA, Mohamed SA, Arafa M, Mohammed SM, Zayed A, Abdelhafez MS, Badawy AM (2020) Anti-IL-6 receptor monoclonal antibody as a new treatment of endometriosis. Immunol Res 68(6):389–397. https://doi.org/10.1007/s12026-020-09147-7 Etzerodt A, Moestrup SK (2013) CD163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxid Redox Signal 18(17):2352–2363. https://doi.org/10.1089/ars.2012.4834 European Society of Human Reproduction and Embryology. (n.d.). ESHRE guideline endometriosis. Retrieved May 5 (2025) from https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Endometriosis-guideline Falcone T, Flyckt R (2018) Clinical management of endometriosis. Obstet Gynecol 131(3):557–571. https://doi.org/10.1097/AOG.0000000000002469 Han, C., Perrone, E., Zeybek, B., Bellone, S., Tymon-Rosario, J., Altwerger, G., Menderes,G., Feinberg, J., Haines, K., Muller Karger, M. E., Bianchi, A., Zammataro, L., Manzano,A., Bonazzoli, E., Manara, P., Buza, N., Hui, P., Ratner, E., Silasi, D. A., Huang,G. S., … Santin, A. D. 2020. In vitro and in vivo activity of sacituzumab govitecan,an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma. Gynecologic oncology, 156(2), 430–438. https://doi.org/10.1016/j.ygyno.2019.11.018 Hogg C, Horne AW, and Elaine Greaves (2020) Endometriosis-Associated macrophages: origin, phenotype, and function. Front Endocrinol 11:7 Hu Y, Zhu Y, Qi D, Zhao X (2024) Trop2-targeted therapy in breast cancer. Biomark Res 12:82. https://doi.org/10.1186/s40364-024-00633-6 Jee BC, Suh CS, Kim SH, Moon SY (2008) Serum soluble CD163 and interleukin-6 levels in women with ovarian endometriomas. Gynecol Obstet Invest 66(1):47–52. https://doi.org/10.1159/000119091 Krasnyi AM, Sadekova AA, Sefihanov TG, Vtorushina VV, Krechetova EG, Khilkevich EG, Arakelyan AS, Pavlovich SV (2019) Soderzhanie tsitokinovIL-6, IL-8, TNF-α, IL-4 i uroven’ Ékspressii Makrofagami CD86 i CD163 v peritoneal’noĭ Zhidkosti Imeet obratnuiu korreliatsiiu so stepen’iu Tiazhesti Naruzhnogo genital’nogo éndometrioza [The content of cytokines IL-6, IL-8, TNF-α, IL-4 and the level of expression in macrophages CD86 and CD163 in peritoneal fluid has a reverse correlation with the degree of severity of external genital endometriosis]. Biomeditsinskaia Khimiia 65(5):432–436 Kusunoki M, Fujiwara Y, Komohara Y, Imamura Y, Honda R, Ohba T, Katabuchi H (2021) Hemoglobin-induced continuous activation of macrophages in endometriotic cysts: a potential mechanism of endometriosis development and carcinogenesis. Med Mol Morphol 54(2):122–132. https://doi.org/10.1007/s00795-020-00266-w Laganà AS, Salmeri FM, Frangež B, Ghezzi H, Vrtačnik-Bokal F, E., Granese R (2020) Evaluation of M1 and M2 macrophages in ovarian endometriomas from women affected by endometriosis at different stages of the disease. Gynecol Endocrinology: Official J Int Soc Gynecol Endocrinol 36(5):441–444. https://doi.org/10.1080/09513590.2019.1683821 McDougall AR, Hooper SB, Zahra VA, Sozo F, Lo CY, Cole TJ, Doran T, Wallace MJ (2011) The oncogene Trop2 regulates fetal lung cell proliferation. Am J Physiol Lung Cell Mol Physiol 301(4):L478–L489. https://doi.org/10.1152/ajplung.00063.2011 Nie MF, Xie Q, Wu YH, He H, Zou LJ, She XL, Wu XQ (2018) Serum and ectopic endometrium from women with endometriosis modulate macrophage M1/M2 polarization via the Smad2/Smad3 pathway. J Immunol Res 2018(6285813). https://doi.org/10.1155/2018/6285813 Nisenblat V, Bossuyt PM, Farquhar C, Johnson N, Hull ML (2016) Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev 2(2):CD009591. https://doi.org/10.1002/14651858.CD009591.pub2 Ozalp CB, Akdogan S, Cetinavci D, Akin MN, Elbe H, Kasap B (2024) Unveiling the placental secrets: exploring histopathological changes and TROP2 expression in intrahepatic cholestasis of pregnancy. Placenta 154:201–206. https://doi.org/10.1016/j.placenta.2024.07.055 Perrone, E., Manara, P., Lopez, S., Bellone, S., Bonazzoli, E., Manzano, A., Zammataro,L., Bianchi, A., Zeybek, B., Buza, N., Tymon-Rosario, J., Altwerger, G., Han, C.,Menderes, G., Huang, G. S., Ratner, E., Silasi, D. A., Azodi, M., Hui, P., Schwartz,P. E., … Santin, A. D. 2020. Sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivo. Molecular oncology, 14(3), 645–656. https://doi.org/10.1002/1878-0261.12627 Rahmawati NY, Ahsan F, Santoso B, Mufid AF, Sa’adi A, Dwiningsih SR, Tunjungseto A, Widyanugraha MYA (2024) Soluble factors CD14, CD163, and migration inhibitory factor are associated with Endometriosis-Related infertility. Gynecol Obstet Invest 89(4):335–345. https://doi.org/10.1159/000538525 Ripani E, Sacchetti A, Corda D, Alberti S (1998) Human Trop-2 is a tumor-associated calcium signal transducer. Int J Cancer 76(5):671–676. Shvartsur A, Bonavida B (2015) Trop2 and its overexpression in cancers: regulation and clinical/therapeutic implications. Genes Cancer 6(3–4):84–105. https://doi.org/10.1177/1947601915581649 Spagnolo E, Martinez A, Mascarós-Martínez A, Marí-Alexandre J, Carbonell M, González-Cantó E, Pena-Burgos EM, Cormack M, Tomás-Pérez BA, Gilabert-Estellés S, López-Carrasco J, Hidalgo A, Ángeles P, Redondo MA, Gallego A, Hernández A, A (2023) Evaluation of immune infiltrates in ovarian endometriosis and endometriosis-Associated ovarian cancer: relationship with histological and clinical features. Int J Mol Sci 24(15):12083. https://doi.org/10.3390/ijms241512083 Sun X, Xing G, Zhang C, Lu K, Wang Y, He X (2020) Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway. Cell Biochem Funct 38(2):141–148. https://doi.org/10.1002/cbf.3450 Symonds I (2020) Essential obstetrics and gynaecology, 6th edn. Elsevier Tanaka T, Ohishi T, Asano T, Takei J, Nanamiya R, Hosono H, Sano M, Harada H, Kawada M, Kaneko MK, Kato Y (2021) An anti–TROP2 monoclonal antibody TrMab–6 exerts antitumor activity in breast cancer mouse xenograft models. Oncol Rep 46(1):132. https://doi.org/10.3892/or.2021.8083 Toda S, Sato S, Saito N, Sekihara K, Matsui A, Murayama D, Nakayama H, Suganuma N, Okubo Y, Hayashi H, Iwasaki H, Miyagi Y, Hoshino D (2022) TROP-2, Nectin-4, GPNMB, and B7-H3 are potentially therapeutic targets for anaplastic thyroid carcinoma. Cancers 14(3):579. https://doi.org/10.3390/cancers14030579 World Endometriosis Society. (n.d.). Endometriosis. Retrieved February 25 (2024) from https://endometriosis.ca/endometriosis/ Wu XG, Chen JJ, Zhou HL, Wu Y, Lin F, Shi J, Wu HZ, Xiao HQ, Wang W (2021) Identification and validation of the signatures of infiltrating immune cells in the eutopic endometrium endometria of women with endometriosis. Front Immunol 12:671201. https://doi.org/10.3389/fimmu.2021.671201 Yüceer RO, Aydın S, Gelir I, Koc T, Tuncer E, Ucar M (2025) Exploring the prognostic role of Trop-2, CD47, and CD163 expression levels on survival outcomes in patients with Triple-Negative breast cancer. Diagnostics (Basel Switzerland) 15(2):232. https://doi.org/10.3390/diagnostics15020232 Zeng P, Chen MB, Zhou LN, Tang M, Liu CY, Lu PH (2016) Impact of TROP2 expression on prognosis in solid tumors: A systematic review and Meta-analysis. Sci Rep 6:33658. https://doi.org/10.1038/srep33658 Zhao W, Ding G, Wen J, Tang Q, Yong H, Zhu H, Zhang S, Qiu Z, Feng Z, Zhu J (2017) Correlation between Trop2 and Amphiregulin coexpression and overall survival in gastric cancer. Cancer Med 6(5):994–1001. https://doi.org/10.1002/cam4.1041 Funding The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. Author information Authors and Affiliations Contributions Planning and conducting the study, data collection, immunohistochemical analysis, light microscopic evaluation was performed by [H.A.], data collection, histochemical analysis, data interpretation was performed by [B.B.], statistical analysis, conducting the study, light microscopic evaluation was performed by [D.C.], planning the study, data interpretation was performed by [O.I.C.], planning the study, light microscopic evaluation, interpretation of the results of all data was performed by [H.E.]. All authors read and approved the final manuscript. Corresponding author Ethics declarations Conflict of interest The authors have no relevant financial or non-financial interests to disclose. Ethical approval Ethical approval was obtained from the Mugla Sitki Kocman University Medical Sciences Ethics Committee (Decision No: 62, Date: 03.06.2024). An ethical approval certificate has been submitted as an attachment. Consent to participate Since this is a retrospective study, no participant consent form is required. Consent to Participate, and Consent to Publish declarations: not applicable. Consent to publish Since this is a retrospective study, no publication consent form is required. Consent to Participate, and Consent to Publish declarations: not applicable. Additional information Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Rights and permissions Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. About this article Cite this article Aydin, H., Bat, B., Cetinavci, D. et al. Immunohistochemical examination of CD163 and TROP2 expression levels in ovarian endometriosis. J Mol Histol 56, 271 (2025). https://doi.org/10.1007/s10735-025-10569-2 Received: Accepted: Published: Version of record: DOI: https://doi.org/10.1007/s10735-025-10569-2